Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2021Frontiers in PharmacologyOpen Access

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients

View Full Paper
Ask AI
Bookmark
Share

Authors

LSLekshmy SrinivasRajiv Gandhi Centre for BiotechnologyNGNoble GraciousFoundation for Innovative New DiagnosticsRNRadhakrishnan R. NairRajiv Gandhi Centre for Biotechnology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Srinivas et al. (2021) studied this question.

synapsesocial.com/papers/6a00205d2ff633f36577d234https://doi.org/10.3389/fphar.2021.726784
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients2014 · 80 citations
  2. 2Tacrolimus dose requirement in relation to donor and recipientABCB1 andCYP3A5 gene polymorphisms in Chinese liver transplant patients2006 · 107 citations
  3. 3Effect of ABCB1 (3435C>T) and CYP3A5 (6986A>G) genes polymorphism on tacrolimus concentrations and dosage requirements in liver transplant patients2016 · 12 citations
  4. 4Prevalence and Predictors of “New-onset Diabetes after Transplantation” (NODAT) in Renal Transplant Recipients: An Observational Study2019 · 26 citations